# Benslie Investment Group

> Benslie Investment Group is a VC fund backing Health Care and Medical Device. See 13 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Total investments: 13
- Last investment: Feb 2022
- Lead investor: 31%
- Last updated: Aug 2026

Benslie Investment Group is a VC fund focused on Health Care and Medical Device. Benslie International Ltd

## Contacts

5 contacts available for Benslie Investment Group. Shizune tracks 1 team members at Benslie Investment Group. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/benslie-international-ltd?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.1M–$6M |
| Series B | $4M–$14M |
| Series C | $25M–$28M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 7 | 54% |
| Medical Device | 6 | 46% |
| Medical | 4 | 31% |
| Fitness | 2 | 15% |
| Wellness | 2 | 15% |

30 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 3 | 23% |
| Series C | 3 | 23% |
| Seed | 2 | 15% |
| Series A | 2 | 15% |
| Funding Round | 2 | 15% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 6 | 46% |
| Israel | 2 | 15% |
| Chile | 1 | 8% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Henry Weinstein | Partner | 1 | https://shizune.co/investors/profile/henry-weinstein |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Medismart | Digital Health company founded in 2018. Founded in Santiago, Chile, in 2022 it internationalized its operations to Colombia and Mexico.The company offers immediate teleconsultation 24 hours a day, 7 days a week in general medicine. Also, scheduling with specialty professionals, mental health, veterinary, dentistry, among others. This can be donethrough the website or the mobile application.Its digital health ecosystem stands out, where patients receive their drug prescriptions and medical exams by email. If the patients wishes, they can buy their medicines with home delivery and/or take medical exams at home.The main sales channel is B2B (Insurers and companies), however it also offers B2C. | $6M | Seed | Feb 01, 2022 |  |
| Wellinks | Wellinks (previously Convexity Scientific) is a New Haven Connecticut based digital health company focused on innovations to reinvent respiratory care around the people who need it. The company began as Convexity Scientific, launching a FDA cleared portable nebulizer, Flyp, to the market in 2018. In transforming to Wellinks, Convexity Scientificacquired an early stage startup in the connected medical device and digital health field. Merging the teams and moving forward under the Wellinks brand, the combined company has created a digital health solution for chronic respiratory disease management that incorporates a suite of connected medical devices and software to enable optimized medication adherence, symptom tracking, diagnostic monitoring, and personalized coaching. | $25M | Series C | Nov 03, 2021 |  |
| Wellinks (formerly Convexity Scientific) | Wellinks is a COPD disease management organization that provides clients with individualized treatment and assistance to help them manage their condition successfully. They focus on each member's individual needs to create a clear route to better health. | $25M | Series C | Nov 03, 2021 |  |
| Black Label | Jasper, formerly CreditStacks, is a financial service company that offers a credit card designed for professionals. Jasper uses technology to assess applicants holistically, so applicants may qualify for a premium Jasper Mastercard, issued by WebBank, even if they are just starting their credit journey.The company was founded in 2015 and isheadquartered in New York City, New York. | $34M | Series A | Mar 01, 2021 |  |
| EyeControl | EyeControl is a pioneer of medical technology, specializing in innovative communication solutions that address unmet healthcare needs. We implement disruptive AI-technologies that connect people and bridge information barriers, facilitating better medical care and decision-making. Our eye-tracking wearable and smart platforms empowercomprehensive, round-the-clock, bi-directional connectivity between patients with communication difficulties, their families, and medical teams. Using adaptive, ML-based pattern recognition, eye gestures are analyzed and converted to real-time communication and actionable clinical data for patients with various levels of cognition. Established in 2016 by individuals, who share unique personal connections to Locked-in patients, EyeControl is a privately held, rapidly growing startup. Recognized as spearheads of cutting-edge medical innovation, the company is supported by the European Innovation Council, Israel Innovation Authority, investors and advisors representing various sectors.The EyeControl device is FDA listed, CE marked, ISO certified, AMAR registered, and HIPAA compliant; it is federally reimbursed in Israel, the UK, and the US. Clinical trials validating its efficacy in detecting and mitigating Delirium are underway in Israel and the US. |  | Series A | Aug 12, 2020 |  |
| Arterys | Arterys is the market leader and the world's first internet platform for medical imaging. Its objective is to transform healthcare by transforming radiology. The Arterys platform is 100% web-based, AI-powered, and FDA-cleared, unlocking simple clinical solutions. | $28M | Series C | May 29, 2020 |  |
| Flyp Nebulizer | Flyp Nebulizer, the medical device is reinvented by Weblinks for respiratory care around the people who need it most. It works at ultrasonic speed to create a fine aerosol of medication. Flyp Nebulizer works quickly to deliver treatment within 7-minute average. | $4M | Series B | Sep 27, 2019 |  |
| Wellinks | Wellinks (previously Convexity Scientific) is a New Haven Connecticut based digital health company focused on innovations to reinvent respiratory care around the people who need it. The company began as Convexity Scientific, launching a FDA cleared portable nebulizer, Flyp, to the market in 2018. In transforming to Wellinks, Convexity Scientificacquired an early stage startup in the connected medical device and digital health field. Merging the teams and moving forward under the Wellinks brand, the combined company has created a digital health solution for chronic respiratory disease management that incorporates a suite of connected medical devices and software to enable optimized medication adherence, symptom tracking, diagnostic monitoring, and personalized coaching. | $14M | Series B | Sep 26, 2019 |  |
| Dog Parker | DogSpot is solving an everyday problem for dog owners and retailers. Our hi-tech doghouse, the DogSpot, sits directly in front of stores that can’t allow dogs inside giving dog owners a safe place for their dogs to wait while they go shopping.Retailers love us because we're changing shopper behavior: shoppers spend 2x as long in-store whenthey use the DogSpot and we keep them health code compliant -- a growing concern as new trends in dog ownership have 87% of dogs going shopping with their owners every week.Current location partners include retail giants Kroger & Albertsons. And advertising partners include two of the biggest pet brands, Purina and Banfield Animal Hospital.Business ModelWe make money three ways: dog owners pay by-the-minute to use the service, location partners pay to make the amenity available to their shoppers and brands pay to advertise with us in our high-traffic locations. | $3.4M |  | Dec 11, 2018 |  |
| Wellinks | Wellinks (previously Convexity Scientific) is a New Haven Connecticut based digital health company focused on innovations to reinvent respiratory care around the people who need it. The company began as Convexity Scientific, launching a FDA cleared portable nebulizer, Flyp, to the market in 2018. In transforming to Wellinks, Convexity Scientificacquired an early stage startup in the connected medical device and digital health field. Merging the teams and moving forward under the Wellinks brand, the combined company has created a digital health solution for chronic respiratory disease management that incorporates a suite of connected medical devices and software to enable optimized medication adherence, symptom tracking, diagnostic monitoring, and personalized coaching. | $3.3M |  | Oct 01, 2017 |  |

10 of 13 investments shown.

## Co-investors
- [Connecticut Innovations](https://shizune.co/investors/profile/connecticut-innovations) — VC Fund, 6 deals together
- [HighCape Partners](https://shizune.co/investors/profile/highcape-partners) — VC Fund, 4 deals together
- [Stonehenge Capital](https://shizune.co/investors/profile/stonehenge-capital) — VC Fund, 4 deals together
- [5Y Capital](https://shizune.co/investors/profile/morningside-ventures) — VC Fund, 2 deals together
- [500 Global](https://shizune.co/investors/profile/500-startups) — VC Fund, 1 deal together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [CORFO](https://shizune.co/investors/profile/corfo) — VC Fund
- [Aster](https://shizune.co/investors/profile/aster-111d) — VC Fund
- [Fen Ventures](https://shizune.co/investors/profile/fen-ventures) — VC Fund

## Featured in investor lists
- [Medical Investors in Chile](https://shizune.co/investors/medical-investors-chile)
- [Medical VC Funds in Chile](https://shizune.co/investors/medical-vc-funds-chile)

## FAQ

### What does Benslie Investment Group invest in?

Benslie Investment Group invests primarily in Health Care, Medical Device and Medical startups, most often at Series B and Series C stage. Most of the 13 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Benslie Investment Group's check size?

Benslie Investment Group typically joins rounds of $1.1M–$6M at Seed, $4M–$14M at Series B and $25M–$28M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Benslie Investment Group participates in.

### How do I contact Benslie Investment Group?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Benslie Investment Group?

The team at Benslie Investment Group includes Henry Weinstein (Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co